• +1-646-491-9876
    • +91-20-67278686

    Search

    Anesthetic Effect - Pipeline Review, H1 2017

    Anesthetic Effect - Pipeline Review, H1 2017

    • Report Code ID: RW0001767501
    • Category Pharmaceuticals
    • No. of Pages 85
    • Publication Month Apr-17
    • Publisher Name Global Markets Direct
    Anesthetic Effect - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Anesthetic Effect - Pipeline Review, H1 2017, provides an overview of the Anesthetic Effect (Central Nervous System) pipeline landscape.

    Anesthetic effect causes a loss of consciousness. The factors that can increase risk of complications include smoking, obstructive sleep apnea, obesity, high blood pressure, history of adverse reactions to anesthesia and drug allergies.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Anesthetic Effect - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Anesthetic Effect (Central Nervous System) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Anesthetic Effect (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Anesthetic Effect and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 3, 2, 1, 3, 15, 1 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

    Anesthetic Effect (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Anesthetic Effect (Central Nervous System) .
    - The pipeline guide reviews pipeline therapeutics for Anesthetic Effect (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Anesthetic Effect (Central Nervous System) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Anesthetic Effect (Central Nervous System) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Anesthetic Effect (Central Nervous System)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Anesthetic Effect (Central Nervous System) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Anesthetic Effect (Central Nervous System) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    Table of Contents 2
    List of Tables 3
    List of Figures 4
    Introduction 5
    Publisher Report Coverage 5
    Anesthetic Effect - Overview 6
    Anesthetic Effect - Therapeutics Development 7
    Pipeline Overview 7
    Pipeline by Companies 8
    Pipeline by Universities/Institutes 10
    Products under Development by Companies 11
    Products under Development by Universities/Institutes 13
    Anesthetic Effect - Therapeutics Assessment 14
    Assessment by Target 14
    Assessment by Mechanism of Action 16
    Assessment by Route of Administration 18
    Assessment by Molecule Type 20
    Anesthetic Effect - Companies Involved in Therapeutics Development 21
    4P Therapeutics LLC 21
    Biolab Farmaceutica Ltda 21
    Drawbridge Pharmaceuticals Pty Ltd 22
    Expanesthetics Inc 22
    Jiangsu Hengrui Medicine Co Ltd 23
    Lee's Pharmaceutical Holdings Ltd 23
    Lipicard Technologies Ltd 24
    NanoMedex Pharmaceuticals Inc 24
    Paion AG 25
    Phosphagenics Ltd 25
    Physica Pharma 26
    Primex Pharmaceuticals Oy 26
    Proteus SA 27
    Sphaera Pharma Pvt Ltd 27
    Taiwan Liposome Company Ltd 28
    The Medicines Company 29
    WEX Pharmaceuticals Inc 29
    Anesthetic Effect - Drug Profiles 30
    alphaxalone - Drug Profile 30
    bupivacaine hydrochloride SR - Drug Profile 32
    Carboetomidate - Drug Profile 33
    gabafol - Drug Profile 34
    HSK-3486 - Drug Profile 35
    lidocaine hydrochloride - Drug Profile 36
    lidocaine hydrochloride - Drug Profile 37
    LT-1121 - Drug Profile 38
    LT-1123 - Drug Profile 39
    MDCO-700 - Drug Profile 40
    Methoxycarbonyl Carboetomidate - Drug Profile 42
    Methoxycarbonyl Etomidate - Drug Profile 43
    midazolam hydrochloride - Drug Profile 45
    neosaxitoxin - Drug Profile 46
    PB-5109 - Drug Profile 48
    PHY-301 - Drug Profile 49
    propofol - Drug Profile 50
    propofol - Drug Profile 51
    propofol - Drug Profile 52
    remimazolam - Drug Profile 53
    remimazolam - Drug Profile 60
    Small Molecule for General Anesthetic Effect - Drug Profile 61
    Small Molecules for General Anesthetic Effect - Drug Profile 62
    Small Molecules to Inhibit NMDA Receptor for Anesthesia - Drug Profile 63
    SPR-819 - Drug Profile 64
    Tetrodotoxin - Drug Profile 65
    TLC-590 - Drug Profile 67
    Anesthetic Effect - Dormant Projects 68
    Anesthetic Effect - Discontinued Products 69
    Anesthetic Effect - Product Development Milestones 70
    Featured News & Press Releases 70
    Appendix 82
    Methodology 82
    Coverage 82
    Secondary Research 82
    Primary Research 82
    Expert Panel Validation 82
    Contact Us 82
    Disclaimer 83

    List of Tables

    Number of Products under Development for Anesthetic Effect, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Companies, H1 2017 (Contd..1) , H1 2017
    Products under Development by Universities/Institutes, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Anesthetic Effect - Pipeline by 4P Therapeutics LLC, H1 2017
    Anesthetic Effect - Pipeline by Biolab Farmaceutica Ltda, H1 2017
    Anesthetic Effect - Pipeline by Drawbridge Pharmaceuticals Pty Ltd, H1 2017
    Anesthetic Effect - Pipeline by Expanesthetics Inc, H1 2017
    Anesthetic Effect - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H1 2017
    Anesthetic Effect - Pipeline by Lee's Pharmaceutical Holdings Ltd, H1 2017
    Anesthetic Effect - Pipeline by Lipicard Technologies Ltd, H1 2017
    Anesthetic Effect - Pipeline by NanoMedex Pharmaceuticals Inc, H1 2017
    Anesthetic Effect - Pipeline by Paion AG, H1 2017
    Anesthetic Effect - Pipeline by Phosphagenics Ltd, H1 2017
    Anesthetic Effect - Pipeline by Physica Pharma, H1 2017
    Anesthetic Effect - Pipeline by Primex Pharmaceuticals Oy, H1 2017
    Anesthetic Effect - Pipeline by Proteus SA, H1 2017
    Anesthetic Effect - Pipeline by Sphaera Pharma Pvt Ltd, H1 2017
    Anesthetic Effect - Pipeline by Taiwan Liposome Company Ltd, H1 2017
    Anesthetic Effect - Pipeline by The Medicines Company, H1 2017
    Anesthetic Effect - Pipeline by WEX Pharmaceuticals Inc, H1 2017
    Anesthetic Effect - Dormant Projects, H1 2017
    Anesthetic Effect - Discontinued Products, H1 2017

    List of Figures

    Number of Products under Development for Anesthetic Effect, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products by Top 10 Targets, H1 2017
    Number of Products by Stage and Top 10 Targets, H1 2017
    Number of Products by Top 10 Mechanism of Actions, H1 2017
    Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
    Number of Products by Routes of Administration, H1 2017
    Number of Products by Stage and Routes of Administration, H1 2017
    Number of Products by Stage and Molecule Types, H1 2017
    4P Therapeutics LLC
    Biolab Farmaceutica Ltda
    Drawbridge Pharmaceuticals Pty Ltd
    Expanesthetics Inc
    Jiangsu Hengrui Medicine Co Ltd
    Lee's Pharmaceutical Holdings Ltd
    Lipicard Technologies Ltd
    NanoMedex Pharmaceuticals Inc
    Paion AG
    Phosphagenics Ltd
    Physica Pharma
    Primex Pharmaceuticals Oy
    Proteus SA
    Sphaera Pharma Pvt Ltd
    Taiwan Liposome Company Ltd
    The Medicines Company
    WEX Pharmaceuticals Inc

    Request for Sample

    Report Url http://www.reportsweb.com//anesthetic-effect-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//anesthetic-effect-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//anesthetic-effect-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments